NDC 66689-790-01 - Sucralfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66689-790
- Requested NDC
- 66689-790-01
- Package NDCs from labels
- 66689-790-01, 66689-790-30, 66689-790-40, 66689-790-50, 66689-790-99
- Manufacturer
- VistaPharm, LLC
- Effective date
- 2023-06-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sucralfate - VistaPharm, LLC | VistaPharm, LLC | 2023-06-20 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66689-790-01 | ML - Milliliter | 66689-790 | 8aaaf07c-3f03-408a-a5e0-76c68da7edc1 | 1 | 2013-02-13 |
| 66689-790-40 | ML - Milliliter | 66689-790 | 68888f93-4247-4f4a-abc9-cbf5348dfd97 | 1 | 2021-08-05 |
| 66689-790-50 | ML - Milliliter | 66689-790 | 150adfc5-acdd-48b9-afb3-8ff277437e6a | 1 | 2013-02-13 |
| 66689-790-99 | ML - Milliliter | 66689-790 | 845bd884-d1a5-4168-8b9b-6cf60a69a862 | 1 | 2020-08-06 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Sucralfate | ACTIVE INGREDIENT | XX73205DH5 | SUCRALFATE SUSPENSION [VISTAPHARM, INC.] | 1 | |
| Sucralfate | ACTIVE MOIETY | XX73205DH5 | SUCRALFATE SUSPENSION [VISTAPHARM, INC.] | 1 | |
| FD&C Red No. 40 | INACTIVE INGREDIENT | WZB9127XOA | SUCRALFATE SUSPENSION [VISTAPHARM, INC.] | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | SUCRALFATE SUSPENSION [VISTAPHARM, INC.] | 1 | |
| Methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | SUCRALFATE SUSPENSION [VISTAPHARM, INC.] | 1 | |
| Sorbitol | INACTIVE INGREDIENT | 506T60A25R | SUCRALFATE SUSPENSION [VISTAPHARM, INC.] | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | SUCRALFATE SUSPENSION [VISTAPHARM, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leader Eye Drops Redness Relief | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Cardinal Health | aee4bbe2-4f11-4c54-be8b-df48b3ba4f3a | 2026-09-09 | Warnings | PDC6A3C0OX |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Rite Aid Corporation | 407c78ca-6fee-4ed6-b61b-711ec049c86e | 2026-09-09 | Warnings | PDC6A3C0OX |
| Clear Eyes Nighttime | GLYCERIN | Prestige Brands Holdings, Inc. | af75e2f7-81dd-43e0-a390-b52bbfbebf62 | 2026-09-08 | Warnings | PDC6A3C0OX |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | CVS Pharmacy | 3167c918-a7d3-46a1-a85b-64f9c22916f2 | 2026-09-04 | Warnings | PDC6A3C0OX |
| Sucralfate | SUCRALFATE | Preferred Pharmaceuticals Inc. | 536b8c00-13ab-4397-a754-63a1c92bf883 | 2026-09-02 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | VistaPharm, LLC | cbfbe146-5d42-4a55-9050-df2b5581487a | 2026-09-02 | Warnings, Adverse reactions | 313123 XX73205DH5 |
| Sucralfate | SUCRALFATE | Preferred Pharmaceuticals Inc. | 5ec71444-cc55-47bd-8abc-b3cfc3b47d8e | 2026-09-01 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Chartwell RX, LLC | 37aee721-b9c7-4e6b-a1a1-e826d8541d6b | 2026-08-27 | Warnings, Adverse reactions | 313123 XX73205DH5 |
| KUGIG ALOE FOAMING INTIMATE WASH | INTIMATE CLEANSING FOAM | Hong Kong KangXing Centennial Management Limited | 59f4d398-1186-a168-e063-6294a90ab44b | 2026-08-26 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | REMEDYREPACK INC. | 5dd5d148-6e23-41de-bff5-551b2aea9598 | 2026-08-24 | Warnings, Adverse reactions | 059QF0KO0R |
| Leader Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | CARDINAL HEALTH 110, LLC. DBA LEADER | 2ded4bda-b3c3-4521-8701-5c8446fd148b | 2026-08-17 | Warnings | PDC6A3C0OX |
| BM BM63 DROPS | CEANOTHUS, KALI ARSEN, KALI MUR, SELENIUM, THALLIUM, WIESBADEN | BM Private Limited | 59006d82-610a-2e08-e063-6394a90af1ed | 2026-08-14 | Warnings | 059QF0KO0R |
| BM BM164 DROPS | ARUM TRYPH, CAUSTICUM, BALSAMUM PERU, HELONIAS DIO, ACID PHOS, GLYCERINUM, EQUISETUM | BM Private Limited | 5902770f-eb01-d099-e063-6394a90ad3eb | 2026-08-14 | Warnings | PDC6A3C0OX |
| Sucralfate | SUCRALFATE | Zydus Lifesciences Limited | 882b7596-f62c-4be2-8f67-e64310718baa | 2026-08-08 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Viona Pharmaceuticals Inc | c708201b-2618-4470-a3ff-8ecf04d6b3a0 | 2026-08-08 | Adverse reactions | XX73205DH5 |
| Sterile Water | WATER | Cardinal Health 107, LLC | 48d75a7c-8329-48a8-bea0-a8c144ddf637 | 2026-08-07 | Warnings, Adverse reactions | 059QF0KO0R |
| CVS Glycerin | GLYCERIN SUPPOISITORY | CVS Pharmacy, Inc | ca6d13db-60e8-4fcc-b7b3-3eb280b8c435 | 2026-08-04 | Warnings | PDC6A3C0OX |
| Garzulys | INSULIN ASPART-FSAN | Meitheal Pharmaceuticals Inc. | 30c64769-d2f7-4604-ac9e-2a6bc09506c9 | 2026-07-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Sucralfate | SUCRALFATE | Cardinal Health 107, LLC | 444a743a-4843-4b33-bad5-3dfc1fb2d004 | 2026-07-29 | Adverse reactions | XX73205DH5 |
| DECONIMO Reconstitution | DECONIMO RECONSTITUTION | Image Amazon LLC | 57ab9b1c-9a18-3786-e063-6394a90a2c63 | 2026-07-28 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.